Increased PLK3 expression corresponds with better disease-related outcome in treated cervical carcinoma and low PLK3 expression is associated with therapeutic resistance and increased metastasis based on immunohistochemical and genomic analyses [190] making PLK3 and its substrate pT273 Caspase 8 a valid prognostic marker. The gene discussed is PLK3; the disease is cervical carcinoma.